Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dieckmann

Showing results (171-180 of 222) with videos related to

Pageof 23
Sort By:
Urologia Internationalis|April 13, 2018
Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First PresentationKlaus-Peter Dieckmann, Hanna Richter-Simonsen, Magdalena Kulejewski, et al.
The Journal of Urology|February 16, 2005
Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 casesKlaus-Peter Dieckmann, Peter Albers, Johannes Classen, et al.
BMJ Simulation & Technology Enhanced Learning|May 6, 2022
Comparison of oral and video debriefing and its effect on knowledge acquisition following simulation-based learningOmer Farooq, Victoria A Thorley-Dickinson, Peter Dieckmann, et al.
Journal of Cancer Research and Clinical Oncology|July 10, 2019
Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?Christian Guido Ruf, Stefan Borck, Petra Anheuser, et al.
Surgical Endoscopy|January 25, 2022
Effects of shared mental models in teams performing video-assisted thoracoscopic surgery lobectomyKirsten Gjeraa, Peter Dieckmann, Katrine Jensen, et al.
Urologia Internationalis|March 19, 2016
MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele FluidKlaus-Peter Dieckmann, Meike Spiekermann, Thomas Balks, et al.
European Urology|November 15, 2011
Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study GroupChristian Winter, David Pfister, Jonas Busch, et al.
Nature Reviews. Urology|March 12, 2020
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumoursKristian Almstrup, João Lobo, Nina Mørup, et al.
Resuscitation|August 25, 2014
Factors relating to the perceived management of emergency situations: a survey of former Advanced Life Support course participants' clinical experiencesMaria B Rasmussen, Martin G Tolsgaard, Peter Dieckmann, et al.
Journal of Cancer Research and Clinical Oncology|April 27, 2016
Testicular seminoma clinical stage 1: treatment outcome on a routine care levelKlaus-Peter Dieckmann, Inken Dralle-Filiz, Cord Matthies, et al.
Pageof 23

Showing results (171-180 of 222) with videos related to

Sort By:
Pageof 23
Urologia Internationalis|April 13, 2018
Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First PresentationKlaus-Peter Dieckmann, Hanna Richter-Simonsen, Magdalena Kulejewski, et al.
The Journal of Urology|February 16, 2005
Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 casesKlaus-Peter Dieckmann, Peter Albers, Johannes Classen, et al.
BMJ Simulation & Technology Enhanced Learning|May 6, 2022
Comparison of oral and video debriefing and its effect on knowledge acquisition following simulation-based learningOmer Farooq, Victoria A Thorley-Dickinson, Peter Dieckmann, et al.
Journal of Cancer Research and Clinical Oncology|July 10, 2019
Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?Christian Guido Ruf, Stefan Borck, Petra Anheuser, et al.
Surgical Endoscopy|January 25, 2022
Effects of shared mental models in teams performing video-assisted thoracoscopic surgery lobectomyKirsten Gjeraa, Peter Dieckmann, Katrine Jensen, et al.
Urologia Internationalis|March 19, 2016
MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele FluidKlaus-Peter Dieckmann, Meike Spiekermann, Thomas Balks, et al.
European Urology|November 15, 2011
Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study GroupChristian Winter, David Pfister, Jonas Busch, et al.
Nature Reviews. Urology|March 12, 2020
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumoursKristian Almstrup, João Lobo, Nina Mørup, et al.
Resuscitation|August 25, 2014
Factors relating to the perceived management of emergency situations: a survey of former Advanced Life Support course participants' clinical experiencesMaria B Rasmussen, Martin G Tolsgaard, Peter Dieckmann, et al.
Journal of Cancer Research and Clinical Oncology|April 27, 2016
Testicular seminoma clinical stage 1: treatment outcome on a routine care levelKlaus-Peter Dieckmann, Inken Dralle-Filiz, Cord Matthies, et al.
Pageof 23